Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks

NCT00240617 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

623

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

DRUG: sumatriptan succinate/naproxen sodium
DRUG: placebo

Sponsor

GlaxoSmithKline